282 related articles for article (PubMed ID: 20532439)
1. Comparison of ivabradine plus beta-blockers versus beta -blocker therapy only.
Aalbers J
Cardiovasc J Afr; 2010; 21(2):116. PubMed ID: 20532439
[TBL] [Abstract][Full Text] [Related]
2. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Tardif JC; Ponikowski P; Kahan T;
Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
[TBL] [Abstract][Full Text] [Related]
4. Angina: Ivabradine for treatment of stable angina pectoris.
de Silva R; Fox KM
Nat Rev Cardiol; 2009 May; 6(5):329-30. PubMed ID: 19377492
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R
Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063
[TBL] [Abstract][Full Text] [Related]
6. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
[TBL] [Abstract][Full Text] [Related]
8. Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.
Koester R; Kaehler J; Ebelt H; Soeffker G; Werdan K; Meinertz T
Clin Res Cardiol; 2010 Oct; 99(10):665-72. PubMed ID: 20454968
[TBL] [Abstract][Full Text] [Related]
9. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
Tendera M; Talajic M; Robertson M; Tardif JC; Ferrari R; Ford I; Steg PG; Fox K;
Am J Cardiol; 2011 Mar; 107(6):805-11. PubMed ID: 21247517
[TBL] [Abstract][Full Text] [Related]
10. Heart rate slowing versus other pharmacological antianginal strategies.
Diaz A; Tardif JC
Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction.
Cammarano C; Silva M; Comee M; Donovan JL; Malloy MJ
Clin Ther; 2016 Feb; 38(2):387-95. PubMed ID: 26839043
[TBL] [Abstract][Full Text] [Related]
12. [Ivabradine -- a novel approach for heart rate lowering].
Er F; Hoppe UC
Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
[No Abstract] [Full Text] [Related]
13. [Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina].
Tatarchenko IP; Pozdniakova NV; Biriuchenko MV
Kardiologiia; 2008; 48(5):60-1. PubMed ID: 18537806
[No Abstract] [Full Text] [Related]
14. Ivabradine versus bisoprolol.
Fazio G; Sarulo F; Licata P; D'Angelo L; Passantino S; Visconti C; Zarcone P; Spanò C; Novo G; Novo S
Minerva Cardioangiol; 2010 Apr; 58(2):281-2. PubMed ID: 20440257
[No Abstract] [Full Text] [Related]
15. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW
Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Werdan K; Ebelt H; Nuding S; Höpfner F; Hack G; Müller-Werdan U
Clin Res Cardiol; 2012 May; 101(5):365-73. PubMed ID: 22231643
[TBL] [Abstract][Full Text] [Related]
17. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
Nedoshivin A; Petrova PTS; Karpov Y
Adv Ther; 2022 Sep; 39(9):4189-4204. PubMed ID: 35842897
[TBL] [Abstract][Full Text] [Related]
19. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
Fox K
Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
[TBL] [Abstract][Full Text] [Related]
20. Stable angina: role of ivabradine unchanged between 2006 and 2010.
Massé JF
Prescrire Int; 2010 Nov; 19(110):264; author reply 264-5. PubMed ID: 21284363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
